STOCK TITAN

Editas Medicine to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Editas Medicine, a leading genome editing company, will participate in several upcoming investor conferences. Key events include Citi’s 15th Annual BioPharma Virtual Conference on September 9, 2020, at 3:20 p.m. ET, a fireside chat at the Wells Fargo 2020 Virtual Healthcare Conference on September 10, 2020, at 10:40 a.m. ET, and another fireside chat at the Morgan Stanley 18th Annual Global Healthcare Conference on September 15, 2020, at 10:15 a.m. ET. These events will be webcast live on the company’s website, with recordings available for 30 days afterwards.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Sept. 04, 2020 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that management will participate in the following upcoming investor conferences:

Citi’s 15th Annual BioPharma Virtual Conference
Panel: Innovation in Cell Therapy
Date: Wednesday, September 9, 2020
Time: 3:20 p.m. ET

Wells Fargo 2020 Virtual Healthcare Conference
Fireside Chat
Date: Thursday, September 10, 2020
Time: 10:40 a.m. ET

Morgan Stanley 18th Annual Global Healthcare Conference
Fireside Chat
Date: Tuesday, September 15, 2020
Time: 10:15 a.m. ET

The events will be webcast live and may be accessed on the Editas Medicine website in the Investors and Media section. Archived recordings will be available for approximately 30 days following the events.

About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Investor Contact
Mark Mullikin
(617) 401-9083
mark.mullikin@editasmed.com

Media Contact
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com


FAQ

What conferences will Editas Medicine attend in September 2020?

Editas Medicine will attend Citi’s 15th Annual BioPharma Virtual Conference on September 9, Wells Fargo 2020 Virtual Healthcare Conference on September 10, and Morgan Stanley 18th Annual Global Healthcare Conference on September 15, 2020.

What is the focus of the events Editas Medicine is participating in?

The events will cover topics such as innovation in cell therapy and include fireside chats with company management.

Where can I watch the Editas Medicine conference webcasts?

The webcasts will be available live on the Editas Medicine website in the Investors and Media section.

How long will the Editas Medicine conference recordings be available?

Archived recordings of the conferences will be accessible for approximately 30 days following the events.

Editas Medicine, Inc.

NASDAQ:EDIT

EDIT Rankings

EDIT Latest News

EDIT Stock Data

203.89M
82.28M
0.32%
70.13%
20.88%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
CAMBRIDGE